These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24664319)
1. Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy. Nagatomo Y; Meguro T; Ito H; Koide K; Anzai T; Fukuda K; Ogawa S; Yoshikawa T PLoS One; 2014; 9(3):e93145. PubMed ID: 24664319 [TBL] [Abstract][Full Text] [Related]
2. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150 [TBL] [Abstract][Full Text] [Related]
4. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity. Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737 [TBL] [Abstract][Full Text] [Related]
13. Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system. De Mello WC; Gerena Y Regul Pept; 2008 Nov; 151(1-3):54-60. PubMed ID: 18585409 [TBL] [Abstract][Full Text] [Related]
14. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457 [TBL] [Abstract][Full Text] [Related]
15. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes. Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors. Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514 [TBL] [Abstract][Full Text] [Related]
17. Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization. Yamada M; Kushibiki M; Osanai T; Tomita H; Okumura K Cardiovasc Res; 2008 Jul; 79(1):169-78. PubMed ID: 18326554 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats. Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy. Leung M; Wong VW; Heritier S; Mihailidou AS; Leung DY Cardiovasc Diabetol; 2013 Oct; 12():139. PubMed ID: 24083804 [TBL] [Abstract][Full Text] [Related]
20. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]